Keeping a closer eye on MJ proxy CBIS with recent acquisitions / bullish Cohen report / Eight new product releases this month in Europe.
They will be presenting at some upcoming conferences latter this month
Patients Out of Time -The Ninth National Clinical Conference on Cannabis Therapeutics May 21-23, 2015 http://www.medicalcannabis.com/ the 28thInternational Conference on Antiviral Research (ICAR) in Rome, Italy.
Earlier this spring, Cohen Research issued an extensive and quite bullish report on CBIS with a .19 price target. They also referred to the stock as a MJ related pure play....
In a few short months, new CEO and President Mr. Raymond C. Dabney has restructured and redirected the business model, adding revenue producing businesses and expanding the CBIS footprint worldwide......Management has built strong partnerships.The Company estimates forecast revenues will grow from $0.1 million in FYE December 31, 2015 to approximately $64.52 million by FYE 2020.